Close
Achema middle east
swop processing & packaging

Clinical Trials

Abivax gets approval to conduct Covid-19 trial in France

Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a Phase...

Vibalogics announces collaboration to provide additional clinical trial material for covid-19 vaccine candidate

Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, announced that it will manufacture additional clinical trial...

Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials

As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid...

Humanigen Initiates Phase III Lenzilumab Study in COVID-19

Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody....

Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution

Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box Clinical...

Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19

Catalent, a global leader in clinical supply services, welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »